These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

936 related items for PubMed ID: 22413927

  • 1. Efficacy and safety of biologics in erythrodermic psoriasis: a multicentre, retrospective study.
    Viguier M, Pagès C, Aubin F, Delaporte E, Descamps V, Lok C, Beylot-Barry M, Séneschal J, Dubertret L, Morand JJ, Dréno B, Bachelez H, Groupe Français de Recherche sur le Psoriasis.
    Br J Dermatol; 2012 Aug; 167(2):417-23. PubMed ID: 22413927
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials.
    Reich K, Burden AD, Eaton JN, Hawkins NS.
    Br J Dermatol; 2012 Jan; 166(1):179-88. PubMed ID: 21910698
    [Abstract] [Full Text] [Related]

  • 3. Erythrodermic psoriasis: current and future role of biologicals.
    Stinco G, Errichetti E.
    BioDrugs; 2015 Apr; 29(2):91-101. PubMed ID: 25752640
    [Abstract] [Full Text] [Related]

  • 4. Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris.
    Gniadecki R, Bang B, Bryld LE, Iversen L, Lasthein S, Skov L.
    Br J Dermatol; 2015 Jan; 172(1):244-52. PubMed ID: 25132294
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term management of erythrodermic psoriasis with anti-TNF agents.
    Romero-Maté A, García-Donoso C, Martinez-Morán C, Hernández-Núñez A, Borbujo J.
    Dermatol Online J; 2010 Jun 15; 16(6):15. PubMed ID: 20579470
    [Abstract] [Full Text] [Related]

  • 7. From biologic to biologic to biologic: lessons to learn for erythrodermic and recalcitrant chronic plaque psoriasis.
    Yip L, Harrison S, Foley P.
    Australas J Dermatol; 2008 Aug 15; 49(3):152-5. PubMed ID: 18638223
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tolerability and safety of biological therapies for psoriasis in daily clinical practice: a study of 103 Italian patients.
    Brunasso AM, Puntoni M, Salvini C, Delfino C, Curcic P, Gulia A, Massone C.
    Acta Derm Venereol; 2011 Jan 15; 91(1):44-9. PubMed ID: 21088813
    [Abstract] [Full Text] [Related]

  • 11. Treatment of erythrodermic psoriasis with biologics: A systematic review.
    Carrasquillo OY, Pabón-Cartagena G, Falto-Aizpurua LA, Santiago-Vázquez M, Cancel-Artau KJ, Arias-Berrios G, Martín-García RF.
    J Am Acad Dermatol; 2020 Jul 15; 83(1):151-158. PubMed ID: 32247872
    [Abstract] [Full Text] [Related]

  • 12. Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept.
    Van Lümig PP, Lecluse LL, Driessen RJ, Spuls PI, Boezeman JB, van de Kerkhof PC, De Jong EM.
    Br J Dermatol; 2010 Oct 15; 163(4):838-46. PubMed ID: 20649798
    [Abstract] [Full Text] [Related]

  • 13. Biologic therapy in psoriasis: perspectives on associated risks and patient management.
    Papp KA, Dekoven J, Parsons L, Pirzada S, Robern M, Robertson L, Tan JK.
    J Cutan Med Surg; 2012 Oct 15; 16(3):153-68. PubMed ID: 22713438
    [Abstract] [Full Text] [Related]

  • 14. Biologic survival.
    Noiles K, Vender R.
    J Drugs Dermatol; 2009 Apr 15; 8(4):329-33. PubMed ID: 19363851
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of plaque psoriasis with biologics. A meta-analysis of randomized controlled trials].
    Zhang Z, Schmitt J, Wozel G, Kirch W.
    Med Klin (Munich); 2009 Feb 15; 104(2):125-36. PubMed ID: 19242664
    [Abstract] [Full Text] [Related]

  • 19. [Biologic therapies in the treatment of psoriasis].
    Farhi D, Dupin N.
    Presse Med; 2009 May 15; 38(5):832-43. PubMed ID: 19282134
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials.
    Brimhall AK, King LN, Licciardone JC, Jacobe H, Menter A.
    Br J Dermatol; 2008 Aug 15; 159(2):274-85. PubMed ID: 18547300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.